Gennex Laboratories Ltd

Pursuant to the provisions of Regulation 30 of the SEBI (LODR) Regulations 2015 (Listing Regulations) read with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11 2024 we wish to inform you that Board of Directors of the Company at its meeting held today on June 04 2025 has considered and approved the following: 1. Allotment of 4000000 Equity Shares upon Conversion of Warrants to the member of promoter group on Preferential basis The requisite disclosures are set out in Annexure A to this letter. We hereby submit that the Board Meeting had commenced at 02:00 PM and concluded at 02.30 PM.This intimation is also uploaded on the Company website: www.gennexlab.comWe request you to take the above information on record and acknowledge the receipt of the same.